Bio

Suzanne Filippi exclusively focuses on US and global corporate transactions in the life sciences industry, representing both multinational pharmaceutical companies and public or private biotechnology companies. Drawing on her deep life sciences industry knowledge, Suzanne counsels clients in a wide range of corporate transactions, with an emphasis on complex license and collaboration agreements, co-commercialization/co-promotion matters, and mergers, acquisitions, and externalizations in the life sciences sector. She is recognized by clients for her collaborative energy, solutions-minded approach, and keen understanding of the unique, mission-focused nature of life sciences companies and their patient populations. Suzanne’s ability to deeply understand a company’s strategic objectives enables her to develop targeted legal solutions that serve her clients’ ambitious business goals. Beyond her robust life sciences practice, she regularly advises on general corporate matters, such as US Securities and Exchange Commission (SEC) compliance, corporate governance, financing, and a range of other everyday legal issues. Suzanne has a command of the complex issues facing companies in critical transition periods—including going public, evolving from a clinical to commercial stage company, M&A integrations and exits, carve-outs, entering new territories, and resolving financial or regulatory challenges. In addition, Suzanne is the leader of the corporate and business transactions practice in the Boston office.